---------- Forwarded message ----------
Arf gene loss enhances oncogenicity and limits imatinib response ...
News-Medical.net - Sydney,Australia
... The investigators studied two types of leukemia: CML - chronic
myelogenous
leukemia, which can now be alleviated to a large extent with a drug called
Gleevec ...
<http://www.news-medical.net/?id=17533>
See all stories on this topic:
<http://news.google.com/news?ie=utf8&oe=utf8&persist=1&hl=en&client=google&ncl=http://www.news-medical.net/%3Fid%3D17533 >http://www.google.com/alerts/manage?hl=en
--~--~---------~--~----~------------~-------~--~----~
[CMLHope]
A support group of http://cmlhope.com
-------------------------------------------------
You received this message because you are subscribed to the Google Groups "CMLHope" group.
To post to this group, send email to [email protected]
To unsubscribe from this group, send email to [EMAIL PROTECTED]
For more options, visit this group at http://groups.google.com/group/CMLHope
-~----------~----~----~----~------~----~------~--~---
